Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Prevail Therapeutics Inc. (PRVL)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-19 | Dec-31-18 |
| Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -526.4% | |
ROIC (including intangibles) | -421.3% | -200.5% |
ROE | -39.8% | -30.7% |
ROA | -35.2% | -25.8% |
|
Cash Conversion Cycle |
Days sales outstanding | | 0.0 |
Days payables outstanding | | 5,206.5 |
Cash conversion cycle | | -5,206.5 |
|